Finding a Needle in a Haystack: Take-Home Naloxone in England 2017/18
Release surveyed each of the 152 local authority areas in England, as local authorities are responsible for commissioning drug services, which give out take-home naloxone. The report includes findings on the availability of take-home naloxone across local authority areas, the scale of take-home naloxone supply in community settings, and coverage among people who use opiates and opiate clients in drug treatment.
Take-home naloxone should be provided in every local authority in England.
Recommendation 2
Local authorities should be giving out at least one take-home naloxone kit for every person using opiates in their area.
Recommendation 3
Local authorities should make take-home naloxone available to any person requesting it, particularly to groups that are at risk of having an opiate-related overdose or are likely to witness someone having an opiate-related overdose.
Recommendation 4
Local authorities should remove any unnecessary requirements to receive take-home naloxone, particularly requirements to engage with services providing take-home naloxone.
Recommendation 5
Local authorities should monitor take-home naloxone provision in their area, including by recording the number of naloxone kits purchased and dispensed, and by monitoring expiry dates of naloxone for recalls and reissues.
Recommendation 6
Support and guidance for local authorities on the local provision of naloxone should be provided nationally in England as a matter of urgency to assist in co-ordination and monitoring of provision and gaps.
Widespread naloxone access is a key policy response to the opioid crisis. Naloxone availability is typically estimated from pharmacy sales, which exclude naloxone provided by community organizations, hospitals, and clinics, or sold over-the-counter. Research objective: To estimate naloxone knowledge, carrying, purchase, and use among US adults.
Naloxone prescriptions to adolescents increased dramatically over the past few years but still are too low given rising rates of opioid overdoses, according to a new study.
Opioids kill more people than any other class of drug. Naloxone is an opioid antagonist which can be distributed in kits for peer administration. Researchers assessed the feasibility of implementing a Take-home Naloxone (THN) intervention in emergency settings, as part of designing a definitive randomised controlled trial (RCT).
Post-overdose outreach, often by public health and public safety partnerships, seeks to connect overdose survivors with naloxone, overdose education, and treatment to reduce the high risk of a subsequent fatal overdose, but outreach strategy and methods vary widely by municipality.
This release by Public Health Scotland presents information on the number of take-home naloxone kits issued by the National Naloxone Programme in Scotland. Figures are presented separately for kits issued from community outlets, kits issued in prisons at the point of prisoner release, kits dispensed via community prescription, and kits issued by Scottish Ambulance Service.
Take home naloxone (THN) programs have been rapidly upscaled in response to increasing opioid-related mortality. One often cited concern is that naloxone provision could be associated with increased opioid use, due to the availability of naloxone to reverse opioid overdose. Researchers conducted a systematic review to determine whether THN provision is associated with changes in substance use by participants enrolled in THN programs.
Do you know of research that should be on this website? If so please let us know about it .
Please include some information about the reseach to help our team decide where is should be on the website.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
